Guizhou Bailing Group Pharmaceutical – World Class Benchmarking
Company: Guizhou Bailing Group Pharmaceutical Company Limited
Bloomberg ticker: 002424 SZ
Market cap: US$1,163m
Background: Guizhou Bailing Group Pharmaceutical Company Limited is a Chinese company specializing in the research, production, and sale of traditional Chinese and Miao ethnic medicines. It operates primarily within China and is known for its Miao medicine products like Yindan XinnaoTong Softgels.
World Class Benchmarking of Guizhou Bailing Group Pharmaceutical
- Profitable Growth rank of 6 was same compared to the prior period’s 6th rank
- This is below average performance compared to 310 medium Health Care companies worldwide
- Profitability rank of 8 was worse than its Growth rank of 2
- Profitability rank of 8 was the same compared to the prior period’s 8th rank
- This is below average performance compared to peers
- Growth rank of 2 was the same compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.